Pages that link to "Q53921660"
Jump to navigation
Jump to search
The following pages link to Leukotriene C4 and D4 in neonates with hypoxemia and pulmonary hypertension. (Q53921660):
Displaying 50 items.
- Leukotrienes in pulmonary arterial hypertension (Q26853496) (← links)
- Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation (Q27687091) (← links)
- Modulation of pulmonary vasomotor tone in the fetus and neonate (Q28362889) (← links)
- Increased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertension (Q28544637) (← links)
- Circulating plasma platelet activating factor in persistent pulmonary hypertension of the newborn (Q33400851) (← links)
- Long-chain polyunsaturated fatty acids and eicosanoids in infants--physiological and pathophysiological aspects and open questions (Q33548053) (← links)
- Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension (Q33593640) (← links)
- Control of the pulmonary circulation in the fetus and during the transitional period to air breathing (Q33700743) (← links)
- The measurement of leukotrienes in human fluids (Q33705493) (← links)
- Pulmonary diseases other than asthma as potential targets for antileukotriene therapy (Q33705523) (← links)
- Functional studies of leukotriene receptors in vascular tissues. (Q33836743) (← links)
- Role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension. (Q34254117) (← links)
- Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology (Q34379865) (← links)
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology (Q34606745) (← links)
- Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice (Q34649842) (← links)
- Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn (Q35084278) (← links)
- The pulmonary circulation in bronchopulmonary dysplasia (Q35095609) (← links)
- The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes (Q35115789) (← links)
- Pathogenic mechanisms of pulmonary arterial hypertension (Q36447388) (← links)
- Immunopathogenetic roles of leukotrienes in human diseases (Q36598890) (← links)
- Prostanoids in bronchoalveolar lavage fluid do not predict outcome in congenital diaphragmatic hernia patients (Q36628177) (← links)
- Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia (Q36628192) (← links)
- Meconium aspiration syndrome: Reflections on a murky subject (Q36748874) (← links)
- Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. (Q37319538) (← links)
- Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease (Q37754750) (← links)
- Regulation of the Pulmonary Circulation in the Fetus and Newborn (Q37801516) (← links)
- Structure and function of the pulmonary vascular bed: an update. (Q38642032) (← links)
- Challenges and opportunities in treating inflammation associated with pulmonary hypertension (Q38812727) (← links)
- The role of eicosanoids in paediatrics (Q39237671) (← links)
- Leukotrienes and the pulmonary microcirculation (Q39510272) (← links)
- Pulmonary hypertension and persistent fetal circulation in the newborn. (Q39645158) (← links)
- Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells (Q39661244) (← links)
- Leukotrienes and the immature pulmonary circulation (Q39661257) (← links)
- Pulmonary hypertension in children: perioperative management (Q39745118) (← links)
- The relation of leukotrienes to liver injury (Q39827561) (← links)
- Prostaglandins, related compounds, and the perinatal pulmonary circulation. (Q40189235) (← links)
- Future research directions in persistent pulmonary hypertension of the newborn. (Q40189251) (← links)
- Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn. (Q40222387) (← links)
- The Role of Nitric Oxide, Endothelin, and Prostaglandins in the Transition of the Pulmonary Circulation (Q40480486) (← links)
- Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved? (Q41845205) (← links)
- Congenital diaphragmatic hernia: impact of prostanoids in the perioperative period (Q42232895) (← links)
- Loop diuretics and in vitro relaxation of human fetal and newborn mouse airways (Q43690556) (← links)
- Effect of 5-lipoxygenase on the development of pulmonary hypertension in rats (Q44730447) (← links)
- Potentiation of leukotriene formation in pulmonary and vascular tissue (Q53910918) (← links)
- The effect of adenosine triphosphate on the functional status of the ductus arteriosus. (Q54107318) (← links)
- Placental vascular responses to leukotriene receptor antagonist FPL 55712. (Q54448140) (← links)
- Extraction of urinary leukotriene E4 by the combined use of octadecyl reversed-phase and NH2 normal-phase extraction columns (Q68078062) (← links)
- Release of leukotriene C4 in respiratory tract during acute viral infection (Q68259501) (← links)
- Detection of leukotrienes B4, C4 and of their isomers in arterial, mixed venous blood and bronchoalveolar lavage fluid from ARDS patients (Q69354958) (← links)
- Pulmonary thromboemboli after neonatal asphyxia (Q70113925) (← links)